Publication|Articles|September 4, 2025
Supplements and Featured Publications
- CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
CAR-T Cell Therapy: Navigating Access, Equity, and Operational Challenges
Listen
0:00 / 0:00
Advertisement
This supplement was sponsored by Johnson & Johnson and Legend Biotech.
In this AJMC® Roundtable discussion, healthcare decision makers examined barriers to timely access to CAR-T cell therapy and identified solutions to streamline approval processes and enhance payer education for improved patient care.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
House Votes to Extend ACA Subsidies, Eyes Turn to Senate
2
Subjective and Objective Impacts of Ambulatory AI Scribes
3
Misalignment Between EHR Penicillin Allergy Flags, Allergist Assessments Signals Need for Improved Documentation
4
Tobacco Use Tied to Immunotherapy Response and Gastric Cancer Mortality
5
























































